News from denovo biopharma llc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 17, 2020, 08:00 ET FDA Grants Fast Track Designation For DB102 in Patients with Newly-Diagnosed Glioblastoma (GBM)

Denovo Biopharma LLC, a pioneer in applying precision medicine to development of innovative therapies, today announced that the U.S. Food and Drug...


Apr 28, 2020, 09:00 ET Denovo Biopharma To Acquire Tocagen's Entire Replicating Gene Therapy Platform and Related Assets

Denovo Biopharma LLC, a pioneer in applying precision medicine to develop innovative therapies, today announced it is acquiring Tocagen's retroviral...


Mar 12, 2020, 08:00 ET Denovo Biopharma Announces Breakthrough Discovery of a Novel Genetic Biomarker for DB104 (Liafensine) for Depression

Denovo Biopharma LLC, a pioneer in applying precision medicine to develop innovative therapies, today announced it has successfully discovered a...


Jan 21, 2020, 09:00 ET Denovo Biopharma Enters into Option Agreement with Rumpus Therapeutics for Selected DB102 (Enzastaurin) Clinical Indications

Denovo Biopharma LLC, a pioneer in applying precision medicine to develop innovative therapies, today announced it has entered into an exclusive...


Dec 06, 2019, 16:00 ET Denovo Biopharma Licenses Global Rights to a Novel Late-Stage Oncology Drug from Sunesis Pharmaceuticals

Denovo Biopharma LLC, a pioneer in applying precision medicine to develop innovative therapies, today announced it has licensed its fifth late-stage...


Jun 18, 2019, 16:00 ET Denovo Biopharma Receives Global Rights to a Novel Late-Stage Drug for Alzheimer's Disease from Orion Corporation for Development as a Personalized Medicine

Denovo Biopharma LLC, a pioneer in applying precision medicine to develop innovative therapies, today announced it has licensed ORM-12741 from Orion...


Feb 21, 2019, 07:00 ET Denovo Biopharma Announces New Hires for Positions of Chief Medical Officer of Hematology and Senior Vice President, Regulatory Affairs and Quality Assurance

Denovo Biopharma, a leader in precision medicine, today announced the hiring of two senior executives, reporting to the CEO: Lei Zhang, MD, as Chief...


Nov 26, 2018, 16:00 ET Two Posters on DB102 (Enzastaurin) Presented at the American Society of Hematology Annual Meeting

Denovo Biopharma LLC, a pioneer in applying precision medicine to develop innovative therapies, today announced the presentation of two posters on...


Jun 04, 2018, 09:00 ET Denovo Biopharma Acquires Exclusive License of Novel Application of DB102 in the Treatment of Pulmonary Arterial Hypertension

Denovo Biopharma LLC, a pioneer in using precision medicine to develop innovative therapies, today announced it has entered into an exclusive global...


May 31, 2018, 02:35 ET Denovo Biopharma to Participate in Jefferies 2018 Global Healthcare Conference

Denovo Biopharma LLC, a pioneer in using precision medicine to develop innovative therapies, today announced that Wen Luo, Ph.D., Chief Executive...


May 29, 2018, 07:30 ET Denovo Biopharma to Participate at Morgan Stanley 4th Annual China Summit

Denovo Biopharma LLC, a pioneer in using precision medicine to develop innovative therapies, today announced that Wen Luo, Ph.D., Chief Executive...


Apr 03, 2018, 04:19 ET First Patient Dosed In Pivotal Biomarker-Guided Phase 3 Study Of First Line Therapy With DB102 (enzastaurin) + R-CHOP In Patients With High-Risk Diffuse Large B-Cell Lymphoma (DLBCL)

Denovo Biopharma LLC, a pioneer in using precision medicine to develop innovative therapies, today announced dosing of the first patient in its...